1. Enhanced Recovery After Surgery Improves Short-term Outcomes in Patients Undergoing Esophagectomy
- Author
-
Zhan-Peng Tang, Cheng-Hao Qu, Chuanle Cheng, Yu Zhang, Shuhai Li, Ming Lu, Lei Qi, Hui Tian, and Lin Li
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,medicine.medical_treatment ,Postoperative Complications ,Humans ,Medicine ,In patient ,Enhanced recovery after surgery ,Aged ,Retrospective Studies ,Perioperative management ,business.industry ,Postoperative complication ,Retrospective cohort study ,Length of Stay ,Esophageal cancer ,medicine.disease ,Surgery ,Esophagectomy ,Treatment Outcome ,Enhanced Recovery After Surgery ,Cardiology and Cardiovascular Medicine ,business ,Older people - Abstract
Enhanced recovery after surgery (ERAS) is a perioperative management protocol used to accelerate patient recovery. This study evaluated its benefits in patients with resectable esophageal cancer.This retrospective study compared patients before (January 2013 to December 2016) and after (June 2018 to December 2020) ERAS protocol implementation in our hospital. A propensity score-matched analysis was used to compare short-term surgical outcomes between ERAS and non-ERAS groups. After propensity score matching each group included 243 patients.There were significant differences in hospital length of stay after surgery (7.40 vs 11.17 days, P.001) and hospitalization cost (¥69380 vs ¥78075, P.001) between the ERAS and non-ERAS groups. The time to chest tube removal (4.91 vs 7.16 days, P.001) and first bowel movement (2.87 vs 3.97 days, P.001) was significantly shorter in the ERAS group. However there was no significant difference in total postoperative complication morbidity (20.2% vs 25.1%, P = .193). The complication of postoperative atelectasis or pneumonia was significantly lower in the ERAS group (P = .003), but there was no significant difference in occurrence of at least grade III complications between the 2 groups (12.3% vs 11.5%, P = .889).We demonstrated that ERAS could reduce hospital stay, numerical pain scores, and hospitalization costs without increasing postoperative complication and readmission. Furthermore subgroup analyses revealed that ERAS was safe for older people (70 years old).
- Published
- 2022